|High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence|
CS Bradshaw, AN Morton, J Hocking, SM Garland, MB Morris, LM Moss, ...
The Journal of infectious diseases 193 (11), 1478-1486, 2006
|Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis|
KA Fethers, CK Fairley, JS Hocking, LC Gurrin, CS Bradshaw
Clinical Infectious Diseases 47 (11), 1426-1435, 2008
|Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure|
CS Bradshaw, SN Tabrizi, TRH Read, SM Garland, CA Hopkins, LM Moss, ...
The Journal of infectious diseases 193 (3), 336-345, 2006
|The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme|
TRH Read, JS Hocking, MY Chen, B Donovan, CS Bradshaw, CK Fairley
Sex Transm Infect 87 (7), 544-547, 2011
|Azithromycin Treatment Failure in Mycoplasma genitalium–Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance|
JS Jensen, CS Bradshaw, SN Tabrizi, CK Fairley, R Hamasuna
Clinical Infectious Diseases 47 (12), 1546-1553, 2008
|Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women|
CK Fairley, JS Hocking, LC Gurrin, MY Chen, B Donovan, CS Bradshaw
Sexually transmitted infections 85 (7), 499-502, 2009
|The Association of Atopobium vaginae and Gardnerella vaginalis with Bacterial Vaginosis and Recurrence after Oral Metronidazole Therapy|
CS Bradshaw, SN Tabrizi, CK Fairley, AN Morton, E Rudland, SM Garland
The Journal of infectious diseases 194 (6), 828-836, 2006
|Sexually transmitted infections: challenges ahead|
M Unemo, CS Bradshaw, JS Hocking, HJC de Vries, SC Francis, ...
The Lancet infectious diseases 17 (8), e235-e279, 2017
|Azithromycin failure in Mycoplasma genitalium urethritis|
CS Bradshaw, JS Jensen, SN Tabrizi, TRH Read, SM Garland, ...
Emerging infectious diseases 12 (7), 1149, 2006
|Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis|
CS Bradshaw, AN Morton, SM Garland, MB Morris, LM Moss, CK Fairley
Obstetrics & Gynecology 106 (1), 105-114, 2005
|Persistence of Mycoplasma genitalium following azithromycin therapy|
CS Bradshaw, MY Chen, CK Fairley
PloS one 3 (11), e3618, 2008
|Macrolide Resistance and Azithromycin Failure in a Mycoplasma genitalium–Infected Cohort and Response of Azithromycin Failures to Alternative Antibiotic …|
M Bissessor, SN Tabrizi, J Twin, H Abdo, CK Fairley, MY Chen, ...
Clinical infectious diseases 60 (8), 1228-1236, 2014
|Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis|
CS Bradshaw, AN Morton, SM Garland, LB Horvath, I Kuzevska, ...
Journal of clinical microbiology 43 (3), 1304-1308, 2005
|Early sexual experiences and risk factors for bacterial vaginosis|
KA Fethers, CK Fairley, A Morton, JS Hocking, C Hopkins, LJ Kennedy, ...
The Journal of infectious diseases 200 (11), 1662-1670, 2009
|Chlamydia trachomatis incidence and re-infection among young women–behavioural and microbiological characteristics|
J Walker, SN Tabrizi, CK Fairley, MY Chen, CS Bradshaw, J Twin, ...
PloS one 7 (5), e37778, 2012
|The role of lactic acid production by probiotic Lactobacillus species in vaginal health|
G Tachedjian, M Aldunate, CS Bradshaw, RA Cone
Research in microbiology 168 (9-10), 782-792, 2017
|Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis|
J Twin, JS Jensen, CS Bradshaw, SM Garland, CK Fairley, LY Min, ...
PloS one 7 (4), e35593, 2012
|The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis|
JE Bilardi, S Walker, M Temple-Smith, R McNair, J Mooney-Somers, ...
PloS one 8 (9), e74378, 2013
|Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use|
CS Bradshaw, LA Vodstrcil, JS Hocking, M Law, M Pirotta, SM Garland, ...
Clinical Infectious Diseases 56 (6), 777-786, 2012
|Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis|
LA Vodstrcil, JS Hocking, M Law, S Walker, SN Tabrizi, CK Fairley, ...
PloS one 8 (9), e73055, 2013